Comparison of nocturnal symptoms in advanced Parkinson’s disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations
Wei Xiang,1 Ya Qing Sun,2 Hui Chin Teoh3 1Medical Affairs, Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, People’s Republic of China; 2Biostatistics and Data Sciences, Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, People’s Republic of China; 3Clinical Ope...
Saved in:
Main Authors: | Xiang W (Author), Sun YQ (Author), Teoh HC (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson's disease
by: D. Yu. Belousov, et al.
Published: (2018) -
The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients
by: Faddoul L, et al.
Published: (2018) -
Formulation and in-vitro anticancer activity of nilotinib immediate release and ibrutinib sustained release pellets
by: Vishal Gupta, et al.
Published: (2024) -
Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
by: K. Arnold Chan, et al.
Published: (2020) -
Insights into the Control of Drug Release from Complex Immediate Release Formulations
by: Runqiao Dong, et al.
Published: (2021)